Anna V. Faino, MS

Biostatistician
Seattle Children's Research Institute

Poster(s):

• (41) Association of Pseudomonas aeruginosa Infection Stage with Lung Function Trajectory In Children with CF>
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (118) Antibiotic Regimen Changes During Pediatric Pulmonary Exacerbation Treatment
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (119) Pulmonary Exacerbation Antibiotic Treatment for Children with Cystic Fibrosis and Polymicrobial Infection
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (195) The impact of elexacaftor/tezacaftor/ivacaftor (Trikafta) on serum markers of fat-soluble vitamin levels in people with cystic fibrosis
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (215) Genetic modifiers of nutritional status in CF are both unique to CF and shared with the general population
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (222) Discovery of Novel Genetic Variants in Severe CF Liver Disease as Determined by Whole Genome Sequencing
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (548) A locus near ICOS is a genetic modifier for risk of Mycobacterium avium complex airway infection in persons with cystic fibrosis.
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET